Insights

Global Market Presence Alfasigma operates in over 100 markets worldwide, including Europe, the Americas, Asia, and Africa, providing extensive opportunities to target regional healthcare providers, distributors, and pharmacies with tailored product offerings and collaborations.

Expanding Portfolio & Strategic Acquisitions Recent mergers and acquisitions, such as the deal with Intercept Pharmaceuticals and the launch of the Morpho CDMO brand, indicate Alfasigma's active growth strategy, opening avenues to offer complementary products, contract manufacturing services, and innovative therapies.

Focus on Specialized Therapeutics With core expertise in Gastroenterology, Vascular, and Rheumatology, there is scope to develop or introduce new medicines, medical devices, or support services targeting healthcare providers specializing in these fields to enhance product adoption.

Technology & R&D Investment Alfasigma’s investment in R&D labs and automation tools suggests a commitment to innovation, making it a potential partner for technologically advanced solutions, clinical trials, and digital health initiatives to streamline development processes.

Strong Financial Backbone With revenues ranging from one to ten billion dollars and significant funding, Alfasigma offers a stable prospect for high-value partnerships, customized licensing agreements, and joint ventures to accelerate product pipelines and market expansion.

Alfasigma Tech Stack

Alfasigma uses 8 technology products and services including Automation Anywhere, UiPath, WordPress, and more. Explore Alfasigma's tech stack below.

  • Automation Anywhere
    Business Process Management
  • UiPath
    Business Process Management
  • WordPress
    Content Management System
  • Oracle
    Enterprise
  • Google Fonts API
    Font Scripts
  • jQuery UI
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • WPForms
    Web Platform Extensions

Media & News

Alfasigma's Email Address Formats

Alfasigma uses at least 1 format(s):
Alfasigma Email FormatsExamplePercentage
First.Last@alfasigma.comJohn.Doe@alfasigma.com
88%
FLast@alfasigma.comJDoe@alfasigma.com
8%
First.MiddleLast@alfasigma.comJohn.MichaelDoe@alfasigma.com
2%
Last.First@alfasigma.comDoe.John@alfasigma.com
2%

Frequently Asked Questions

Where is Alfasigma's headquarters located?

Minus sign iconPlus sign icon
Alfasigma's main headquarters is located at Via Ragazzi del '99, n.5, Bologna, BO 40133, IT. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Alfasigma's official website and social media links?

Minus sign iconPlus sign icon
Alfasigma's official website is alfasigma.com and has social profiles on LinkedInCrunchbase.

What is Alfasigma's NAICS code?

Minus sign iconPlus sign icon
Alfasigma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Alfasigma have currently?

Minus sign iconPlus sign icon
As of October 2025, Alfasigma has approximately 2.5K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: F. B.Chief Technical Operations Officer: F. R.Chief Commercial Officer - Growth Markets: A. S.. Explore Alfasigma's employee directory with LeadIQ.

What industry does Alfasigma belong to?

Minus sign iconPlus sign icon
Alfasigma operates in the Pharmaceutical Manufacturing industry.

What technology does Alfasigma use?

Minus sign iconPlus sign icon
Alfasigma's tech stack includes Automation AnywhereUiPathWordPressOracleGoogle Fonts APIjQuery UIGoogle Tag ManagerWPForms.

What is Alfasigma's email format?

Minus sign iconPlus sign icon
Alfasigma's email format typically follows the pattern of First.Last@alfasigma.com. Find more Alfasigma email formats with LeadIQ.

How much funding has Alfasigma raised to date?

Minus sign iconPlus sign icon
As of October 2025, Alfasigma has raised $176M in funding. The last funding round occurred on Jul 08, 2025 for $176M.
Alfasigma

Alfasigma

Pharmaceutical ManufacturingItaly1001-5000 Employees

Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan). 

The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo).

Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers. 

It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.

Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/

Section iconCompany Overview

Headquarters
Via Ragazzi del '99, n.5, Bologna, BO 40133, IT
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $176M

    Alfasigma has raised a total of $176M of funding over 1 rounds. Their latest funding round was raised on Jul 08, 2025 in the amount of $176M.

  • $1B$10B

    Alfasigma's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $176M

    Alfasigma has raised a total of $176M of funding over 1 rounds. Their latest funding round was raised on Jul 08, 2025 in the amount of $176M.

  • $1B$10B

    Alfasigma's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.